Cerevel Therapeutics Holdings IncNASDAQ:CERE
- LAST PRICE40.0200
- TODAY'S CHANGE (%)-0.2400 (-0.5961%)
- Bid / Lots40.0200/ 1
- Ask / Lots41.2300/ 1
- Open / Previous Close40.2200 / 40.2600
- Day Range
- 52 Week Range
- Volume784,077
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CERE |
|---|---|---|
| 09:32 ET | 5776 | 40.31 |
| 09:34 ET | 8657 | 40.46 |
| 09:36 ET | 5121 | 40.41 |
| 09:38 ET | 8705 | 40.47 |
| 09:39 ET | 3476 | 40.43 |
| 09:41 ET | 2600 | 40.47 |
| 09:43 ET | 2005 | 40.49 |
| 09:45 ET | 900 | 40.52 |
| 09:48 ET | 2130 | 40.53 |
| 09:50 ET | 1620 | 40.505 |
| 09:52 ET | 4380 | 40.52 |
| 09:54 ET | 3600 | 40.5 |
| 09:56 ET | 1000 | 40.5 |
| 09:57 ET | 3000 | 40.505 |
| 09:59 ET | 900 | 40.525 |
| 10:01 ET | 4201 | 40.525 |
| 10:03 ET | 2200 | 40.52 |
| 10:06 ET | 3171 | 40.56 |
| 10:08 ET | 300 | 40.555 |
| 10:10 ET | 3085 | 40.625 |
| 10:12 ET | 1800 | 40.59 |
| 10:14 ET | 3086 | 40.57 |
| 10:15 ET | 1624 | 40.6 |
| 10:17 ET | 1624 | 40.575 |
| 10:19 ET | 700 | 40.59 |
| 10:24 ET | 1952 | 40.585 |
| 10:28 ET | 100 | 40.61 |
| 10:30 ET | 3500 | 40.59 |
| 10:32 ET | 400 | 40.585 |
| 10:33 ET | 600 | 40.585 |
| 10:35 ET | 500 | 40.595 |
| 10:37 ET | 1600 | 40.585 |
| 10:39 ET | 7030 | 40.5925 |
| 10:42 ET | 1606 | 40.6 |
| 10:44 ET | 300 | 40.585 |
| 10:46 ET | 200 | 40.6 |
| 10:48 ET | 800 | 40.6 |
| 10:50 ET | 500 | 40.61 |
| 10:51 ET | 400 | 40.585 |
| 10:53 ET | 800 | 40.555 |
| 10:55 ET | 300 | 40.56 |
| 10:57 ET | 1300 | 40.555 |
| 11:00 ET | 500 | 40.555 |
| 11:02 ET | 1100 | 40.555 |
| 11:04 ET | 600 | 40.555 |
| 11:06 ET | 100 | 40.555 |
| 11:08 ET | 1454 | 40.55 |
| 11:09 ET | 5800 | 40.55 |
| 11:11 ET | 300 | 40.55 |
| 11:13 ET | 200 | 40.555 |
| 11:15 ET | 778 | 40.55 |
| 11:18 ET | 1532 | 40.555 |
| 11:20 ET | 4064 | 40.5537 |
| 11:22 ET | 2600 | 40.55 |
| 11:24 ET | 2961 | 40.565 |
| 11:26 ET | 900 | 40.58 |
| 11:27 ET | 300 | 40.575 |
| 11:29 ET | 2142 | 40.55 |
| 11:31 ET | 4422 | 40.49 |
| 11:33 ET | 300 | 40.5 |
| 11:36 ET | 700 | 40.495 |
| 11:38 ET | 900 | 40.505 |
| 11:40 ET | 400 | 40.51 |
| 11:42 ET | 300 | 40.5 |
| 11:44 ET | 400 | 40.465 |
| 11:45 ET | 100 | 40.465 |
| 11:47 ET | 546 | 40.475 |
| 11:51 ET | 1164 | 40.475 |
| 11:54 ET | 500 | 40.465 |
| 11:56 ET | 4551 | 40.51 |
| 11:58 ET | 3000 | 40.505 |
| 12:00 ET | 700 | 40.51 |
| 12:03 ET | 200 | 40.505 |
| 12:07 ET | 300 | 40.515 |
| 12:09 ET | 600 | 40.51 |
| 12:12 ET | 900 | 40.5 |
| 12:14 ET | 5738 | 40.495 |
| 12:16 ET | 400 | 40.5 |
| 12:18 ET | 100 | 40.5 |
| 12:20 ET | 8364 | 40.505 |
| 12:21 ET | 1401 | 40.51 |
| 12:23 ET | 3857 | 40.46 |
| 12:25 ET | 2805 | 40.405 |
| 12:27 ET | 900 | 40.41 |
| 12:30 ET | 505 | 40.405 |
| 12:32 ET | 600 | 40.375 |
| 12:34 ET | 400 | 40.35 |
| 12:36 ET | 2983 | 40.345 |
| 12:38 ET | 1454 | 40.325 |
| 12:41 ET | 806 | 40.305 |
| 12:43 ET | 8443 | 40.33 |
| 12:45 ET | 400 | 40.33 |
| 12:48 ET | 2700 | 40.315 |
| 12:50 ET | 30224 | 40.3 |
| 12:52 ET | 5515 | 40.255 |
| 12:54 ET | 800 | 40.265 |
| 12:56 ET | 1000 | 40.27 |
| 12:57 ET | 2395 | 40.25 |
| 12:59 ET | 315 | 40.24 |
| 01:01 ET | 1537 | 40.245 |
| 01:03 ET | 600 | 40.22 |
| 01:06 ET | 1062 | 40.225 |
| 01:08 ET | 814 | 40.225 |
| 01:10 ET | 2220 | 40.23 |
| 01:12 ET | 200 | 40.235 |
| 01:14 ET | 3409 | 40.26 |
| 01:15 ET | 600 | 40.25 |
| 01:17 ET | 942 | 40.245 |
| 01:19 ET | 1800 | 40.22 |
| 01:24 ET | 100 | 40.245 |
| 01:26 ET | 2000 | 40.235 |
| 01:28 ET | 1414 | 40.24 |
| 01:30 ET | 1000 | 40.23 |
| 01:32 ET | 770 | 40.235 |
| 01:33 ET | 1346 | 40.225 |
| 01:35 ET | 801 | 40.245 |
| 01:37 ET | 300 | 40.245 |
| 01:39 ET | 700 | 40.25 |
| 01:42 ET | 1883 | 40.25 |
| 01:44 ET | 1200 | 40.255 |
| 01:46 ET | 500 | 40.26 |
| 01:48 ET | 4040 | 40.25 |
| 01:50 ET | 2143 | 40.24 |
| 01:51 ET | 1600 | 40.225 |
| 01:53 ET | 506 | 40.23 |
| 01:57 ET | 1400 | 40.24 |
| 02:00 ET | 3400 | 40.235 |
| 02:02 ET | 8489 | 40.25 |
| 02:04 ET | 1800 | 40.225 |
| 02:06 ET | 911 | 40.22 |
| 02:08 ET | 200 | 40.215 |
| 02:09 ET | 1600 | 40.205 |
| 02:11 ET | 600 | 40.2 |
| 02:13 ET | 600 | 40.2 |
| 02:15 ET | 3612 | 40.205 |
| 02:18 ET | 500 | 40.205 |
| 02:20 ET | 200 | 40.205 |
| 02:22 ET | 37530 | 40.155 |
| 02:24 ET | 1592 | 40.155 |
| 02:26 ET | 2581 | 40.115 |
| 02:27 ET | 600 | 40.11 |
| 02:29 ET | 1404 | 40.09 |
| 02:31 ET | 850 | 40.075 |
| 02:33 ET | 300 | 40.07 |
| 02:36 ET | 2202 | 40.11 |
| 02:38 ET | 300 | 40.1 |
| 02:40 ET | 300 | 40.11 |
| 02:42 ET | 800 | 40.09 |
| 02:44 ET | 2000 | 40.12 |
| 02:45 ET | 300 | 40.135 |
| 02:47 ET | 5786 | 40.135 |
| 02:49 ET | 510 | 40.13 |
| 02:51 ET | 3329 | 40.1 |
| 02:54 ET | 500 | 40.095 |
| 02:56 ET | 200 | 40.09 |
| 02:58 ET | 2340 | 40.095 |
| 03:00 ET | 401 | 40.11 |
| 03:02 ET | 2181 | 40.095 |
| 03:03 ET | 3337 | 40.1 |
| 03:05 ET | 100 | 40.095 |
| 03:07 ET | 4297 | 40.075 |
| 03:09 ET | 3592 | 40.095 |
| 03:12 ET | 2200 | 40.095 |
| 03:14 ET | 5080 | 40.085 |
| 03:16 ET | 1072 | 40.1 |
| 03:18 ET | 100 | 40.1099 |
| 03:20 ET | 37339 | 40.02 |
| 03:21 ET | 19307 | 39.965 |
| 03:23 ET | 3221 | 39.96 |
| 03:25 ET | 1100 | 39.95 |
| 03:27 ET | 4913 | 39.985 |
| 03:30 ET | 7371 | 40 |
| 03:32 ET | 1200 | 40 |
| 03:34 ET | 4984 | 40 |
| 03:36 ET | 7867 | 40.04 |
| 03:38 ET | 2115 | 40.035 |
| 03:39 ET | 2188 | 40.045 |
| 03:41 ET | 7388 | 40.07 |
| 03:43 ET | 8839 | 40.09 |
| 03:45 ET | 3200 | 40.03 |
| 03:48 ET | 6732 | 40.055 |
| 03:50 ET | 5810 | 40.02 |
| 03:52 ET | 5187 | 40.025 |
| 03:54 ET | 12098 | 39.975 |
| 03:56 ET | 8932 | 39.95 |
| 03:57 ET | 28822 | 39.985 |
| 03:59 ET | 37069 | 40.02 |
Today
CEREVEL NEWS NOTICE: BFA Law Informs Cerevel (CERE) Shareholders of Investigation into the $45 Merger Offer, Contact the Firm About Your Rights, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesCalling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesCEREVEL NEWS ALERT: BFA Law Announces Investigation of Cerevel (Nasdaq:CERE) Over the $45 Merger Offer, Investors are Encouraged to Contact the Firm, from 9 hours ago by Dow Jones
9 hours ago by Dow Jones
Yesterday
CEREVEL INVESTIGATION NEWS: Cerevel (CERE) Investors are Urged to Contact BFA Law About Their Rights in the $45 Merger Offer from AbbVie, from 3:28PM ET on Thursday Jun 06, 2024 by Dow Jones
3:28PM ET on Thursday Jun 06, 2024 by Dow JonesCalling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses, from 11:01AM ET on Thursday Jun 06, 2024 by Dow Jones
11:01AM ET on Thursday Jun 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cerevel Therapeutics Holdings Inc | 7.4B | -14.7x | --- |
Vaxcyte Inc | 7.6B | -16.8x | --- |
Viking Therapeutics Inc | 6.9B | -60.2x | --- |
Revolution Medicines Inc | 6.3B | -10.7x | --- |
Summit Therapeutics Inc | 6.1B | -46.6x | --- |
Cytokinetics Inc | 5.6B | -9.8x | --- |
Company Information
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4). Darigabat is a PAM that selectively targets the alpha 2/3/5 subunits of the GABAA receptor. Tavapadon is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of Parkinson’s disease.
Contact Information
- Headquarters
- 222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
- Phone
- 212-284-2300
- Fax
- 302-636-5454
Executives
- Chairperson of the Board of Directors
- N. Anthony Coles
- President, Chief Executive Officer, Member of the Board
- Ronald Renaud
- Chief Financial Officer
- Susan Altschuller
- Chief Human Resources Officer
- Kenneth Dipietro
- Senior Vice President - Finance, Chief Accounting Officer
- Mark Bodenrader
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.4B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 182.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-2.72 |
Book Value | $3.71 |
P/E Ratio | -14.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
